• 검색어에 아래의 연산자를 사용하시면 더 정확한 검색결과를 얻을 수 있습니다.
  • 검색연산자
검색연산자 기능 검색시 예
() 우선순위가 가장 높은 연산자 예1) (나노 (기계 | machine))
공백 두 개의 검색어(식)을 모두 포함하고 있는 문서 검색 예1) (나노 기계)
예2) 나노 장영실
| 두 개의 검색어(식) 중 하나 이상 포함하고 있는 문서 검색 예1) (줄기세포 | 면역)
예2) 줄기세포 | 장영실
! NOT 이후에 있는 검색어가 포함된 문서는 제외 예1) (황금 !백금)
예2) !image
* 검색어의 *란에 0개 이상의 임의의 문자가 포함된 문서 검색 예) semi*
"" 따옴표 내의 구문과 완전히 일치하는 문서만 검색 예) "Transform and Quantization"
쳇봇 이모티콘
ScienceON 챗봇입니다.
궁금한 것은 저에게 물어봐주세요.

논문 상세정보

HILIC-MS determination of dimethylamine in the active pharmaceutical ingredients and in the dosage forms of metformin


Abstract A sensitive and specific hydrophilic interaction chromatography (HILIC) method for the separation and determination of dimethylamine (DMA) in active pharmaceutical ingredients (APIs) and in dosage forms of metformin (MET) has been developed and validated. A feasible analytical method based on HILIC coupled with mass spectrometry detection (HILIC-MS) was established using a simple sample preparation. The separation of MET was achieved on a Cortecs HILIC column using a mixture of 10 mmol/L ammonium formate adjusted to pH 4.8 and acetonitrile (25:75, v/v) at 0.8 mL/min flow rate. The a single-quadrupole mass detector was operated in positive ion mode. Quadrupole mass analyser was employed in selected ion monitoring mode using a target ion at m/z = 46 as [M+H]+. The HILIC-MS method was validated as per International Council on Harmonization (ICH) guidelines in terms of linearity, limit of detection, limit of quantification, selectivity, accuracy, precision and intermediate precision. The main benefit of the HILIC-MS method is a simple sample pretreatment and a quick and sensitive HILIC-MS analysis. The method was demonstrated to be applicable for the determination of DMA in routine quality control evaluation of commercial samples of metformin of both API and dosage forms. The HILIC-MS method was developed as a simpler and faster alternative to compendial method for determination of DMA (as specific impurity F) in MET described in European Pharmacopoeia. Highlights The HILIC-MS method allows fast determination of dimethylamine in samples of metformin. LOQ of dimethylamine was 2.5 ng/mL. The HILIC-MS method does not require any derivatization. The analysis time of sample using HILIC-MS method is 5 min. The method was fully validated in according ICH guidelines.


참고문헌 (23)

  1. 1. Ann. Intern. Med. Maruthur 164 740 2016 10.7326/M15-2650 Diabetes medications as monotherapy or metformin-based combination therapy for type 2 diabetes: a systematic review and meta-analysis 
  2. 2. Pract. Diabetes Int. Bailey 21 115 2004 10.1002/pdi.606 Metformin: its botanical background 
  3. 3. J. Chem. Soc. Perkin Trans. I Werner 121 1790 1922 10.1039/CT9222101790 The preparation of methylguanidine, and of ββ-dimethylguanidine by the interaction of dicyandiamide, and methylammonium and dimethylammonium chlorides respectively 
  4. 4. Patent Fr2322860a1, Dimethylbiguanide hydrochloride preparation by reaction of hydrogen chloride gas with a concentration solution of dimethylamine and dicyandiamide in xylene. (1975). 
  5. 5. Environ. Sci. Technol. Mitch 36 588 2002 10.1021/es010684q Formation of N-Nitrosodimethylamine (NDMA) from dimethylamine during chlorination 
  6. 6. Chemosphere. Sgroi 191 685 2018 10.1016/j.chemosphere.2017.10.089 N-Nitrosodimethylamine (NDMA) and its precursors in water and wastewater: a review on formation and removal 
  7. 7. U.S. Environmental Protection Agency, Integrated Risk Information System (IRIS), https://cfpub.epa.gov/ncea/iris/iris_documents/documents/subst/0045_summary.pdf. 
  8. 8. J. Lauerman, Diabetes drugs latest to be targeted for carcinogen scrutiny. Bloomberg Business. Retrieved January 5, 2020. 
  9. 9. D. Koenig, FDA Investigating metformin for possible carcinogen. Medscape. Retrieved December 14, 2019, https://www.medscape.com/viewarticle/922248. 
  10. 10. European Pharmacopoeia 9.0, 01/2017:0931 Metformin Hydrochloride. 
  11. 11. Indones. J. Pharm. Sci. Technol. Gopalakrishnan 78 409 2016 Determination of dimethylamine and triethylamine in hydrochloride salts of drug substances by headspace gas chromatography using dimethyl sulphoxide-imidazole as diluent 
  12. 12. J. Chrom. B Biomed. Sci. Appl. Teerlink 691 269 1997 10.1016/S0378-4347(96)00476-8 Determination of dimethylamine in biological samples by high-performance liquid chromatography 
  13. 13. J. Chrom. A Lopez 721 231 1996 10.1016/0021-9673(95)00787-3 Determination of dimethylamine in groundwater by liquid chromatography and precolumn derivatization with 9-fluorenylmethylchloroformate 
  14. 14. J. Chrom.B Analyt. Technol. Biomed. Life Sci. Awwad 1038 12 2016 10.1016/j.jchromb.2016.10.017 Determination of trimethylamine, trimethylamine N-oxide, and taurine in human plasma and urine by UHPLC-MS/MS technique 
  15. 15. MethodsX S.Veeravalli 4 310 2017 10.1016/j.mex.2017.09.004 A highly sensitive liquid chromatography electrospray ionization mass spectrometry method for quantification of TMA, TMAO and creatinine in mouse urine 
  16. 16. J. Sep. Sci. Dou?a 37 739 2014 10.1002/jssc.201301348 Retention behavior of a homologous series and positional isomers of aliphatic amino acids in hydrophilic interaction chromatography 
  17. 17. J. Chromatogr. Sci. Dou?a 54 119 2016 10.1093/chromsci/bmw116 HILIC-MS determination of genotoxic impurity of 2-chloro-N-(2-chloroethyl)ethanamine in the vortioxetine manufacturing process 
  18. 18. J. Chromatogr. A Viidanoja 1480 106 2017 10.1016/j.chroma.2016.12.037 Quantitation of short chain amines in aqueous matrices using liquid chromatography electrospray ionization tandem mass spectrometry 
  19. 19. European Pharmacopoeia, 6th ed. (2009) Strasbourg: Council of Europe, pp 4407-4413. 
  20. 20. ICH Q2(R1) 2005 Validation of Analytical Procedures; Step 4 Version 
  21. 21. Accredit. Qual. Assur. Van Loco 7 281 2002 10.1007/s00769-002-0487-6 Linearity of calibration curves: use and misuse of the correlation coefficient 
  22. 22. Int. J. Clin. Pharmacol. Ther. Atiqi 47 153 2009 10.5414/CPP47153 Accuracy assessments of quantitative diagnostic tests for clinical research 
  23. 23. 10.6028/NIST.TN.1297 B.N. Taylor, C.E. Kuyatt, Guidelines for evaluating and expressing the uncertainty of NIST measurement results. NIST Technical Note 1297, 1994 Edition. 

DOI 인용 스타일

"" 핵심어 질의응답